Gyon Technologies Capital Management, LP Dexcom Inc Transaction History

Gyon Technologies Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $698,450 - $1.01 Million	-8,219 Reduced 59.61%	5,570 $630,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $73,906 - $91,166	968 Added 7.55%	13,789 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $871,699 - $1.7 Million	12,821 New	12,821 $956,000
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $182,515 - $252,587	-1,940 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $373,116 - $467,781	-2,873 Reduced 59.69%	1,940 $1.04 Million
Q3 2021 Nov 18, 2021	BUY	$106.71 - $143.18 $140,857 - $188,997	1,320 Added 37.79%	4,813 $2.63 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $155,581 - $207,333	1,921 Added 122.2%	3,493 $1.49 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $238,768 - $294,947	-2,816 Reduced 64.18%	1,572 $565,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $342,264 - $458,546	4,388 New	4,388 $1.62 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.